Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Amber Robinson, PhD
Centers for Disease Control and Prevention
Study Director - Dick Menzies, MD
McGill University
Study Chair - Robert Belknap, MD
Denver Public Health (USA)
Study Chair - Rosanna M Boyd, PhD
Centers for Disease Control (USA)
Study Director - Timothy Sterling, MD
Vanderbilt University Medical Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Liverpool Hospital
Sydney, Australia
Recruiting - Paramatta Chest
Sydney, Australia
Recruiting - Royal Prince Alfred Hospital
Sydney, Australia
Recruiting
- National Referral University Hospital for Pneumo-Physiology
Cotonou, Benin
Active, not recruiting
- Calgary Tb Clinic
Calgary, Alberta, Canada
Recruiting - Edmonton Tb Clinic
Edmonton, Alberta, Canada
Recruiting - British Columbia Centre for Disease Control
Vancouver, British Columbia, Canada
Recruiting - Toronto Western Hospital
Toronto, Ontario, Canada
Recruiting - Mcgill University Health Centre
Montreal, Quebec, Canada
Recruiting
- Les Centres Gheskio (inlr) Crs
Port-au-Prince, Haiti
Recruiting
- Desmond Tutu Tb Center
Stellenbosch, South Africa
Not, yet, recruiting
- Joint Clinical Research Centre/ Makerere Univ Med Sch
Kampala, Uganda
Recruiting
- Denver Health and Hospital Authority
Denver, Colorado, United States
Recruiting - George Washington University
Washington D.C., District of Columbia, United States
Recruiting - Washington Dc Va Medical Center
Washington D.C., District of Columbia, United States
Recruiting - New York Harbor Healthcare System
Manhattan, New York, United States
Recruiting - New York City Bureau of Tb Control
New York, New York, United States
Recruiting - San Antonio Va
San Antonio, Texas, United States
Active, not recruiting - Seattle King County Health Department
Seattle, Washington, United States
Recruiting
- Ho Chin Minh City-District 6 Tb Unit
Ho Chi Minh City, Vietnam
Recruiting - Ho Chin Minh City-Phoi Viet Resportory Centre
Ho Chi Minh City, Vietnam
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Aug 2019
- Primary completion
- 31 Dec 2029
- Completion
- 31 Dec 2029
- Last update posted
- 6 May 2026
- Registered enrollment
- 3,400
- Registry id
- NCT03474029
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.